These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 13087338)

  • 21. [Problem of the blood pressure reduction by iron saccharates].
    STILLE G; MEYER F
    Arzneimittelforschung; 1953 Mar; 3(3):145-7. PubMed ID: 13066365
    [No Abstract]   [Full Text] [Related]  

  • 22. Histological appearances following intravenous saccharated iron oxide, and the factors governing precipitation of the compound in vivo.
    NISSIM JA
    Guys Hosp Rep; 1953; 102(2):164-79. PubMed ID: 13044079
    [No Abstract]   [Full Text] [Related]  

  • 23. Safety of intravenous injection of iron saccharate in haemodialysis patients.
    Sunder-Plassmann G; Hörl WH
    Nephrol Dial Transplant; 1996 Sep; 11(9):1797-802. PubMed ID: 8918625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hematological response of pregnant to saccharated iron oxide].
    NICHOLSON DB; ASSALI NS
    Dia Med; 1952 Aug; 24(55):1431-4. PubMed ID: 13020745
    [No Abstract]   [Full Text] [Related]  

  • 25. DISTRIBUTION OF INTRAVENOUSLY ADMINISTERED SACCHARATED IRON OXIDE IN THE POPLITEAL LYMPH NODE OF THE RABBIT.
    MENZIES DW; RYAN GB
    Nature; 1964 Jul; 203():309-10. PubMed ID: 14201777
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of the injection of saccharated iron oxide on the phagocytic activity of the reticuloendothelial system in the rat].
    BENACERRAF B; BIOZZI G; STIFFEL C
    C R Seances Soc Biol Fil; 1956 Nov; 150(6):1161-4. PubMed ID: 13383921
    [No Abstract]   [Full Text] [Related]  

  • 27. Ferumoxytol: an intravenous iron, riskier than iron sucrose.
    Prescrire Int; 2013 Sep; 22(141):206. PubMed ID: 24171212
    [No Abstract]   [Full Text] [Related]  

  • 28. [Iron deficiency. When parenteral substitution?].
    Kosch M; Schaefer RM
    MMW Fortschr Med; 2001 Feb; 143(6):38-9. PubMed ID: 11247361
    [No Abstract]   [Full Text] [Related]  

  • 29. Intravenous iron sucrose: an alternative for oral iron in pregnancy with iron deficiency anemia.
    Shi Q; Li J; Yao Q; Mi C; Yang J; Xing A
    Ann Hematol; 2015 Mar; 94(3):523-5. PubMed ID: 25123238
    [No Abstract]   [Full Text] [Related]  

  • 30. Delayed adverse reactions to iron polymaltose and iron sucrose.
    Tampi R
    Intern Med J; 2010 Feb; 40(2):166-7. PubMed ID: 20446963
    [No Abstract]   [Full Text] [Related]  

  • 31. Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose.
    Christoph P; Schuller C; Studer H; Irion O; De Tejada BM; Surbek D
    J Perinat Med; 2012 May; 40(5):469-74. PubMed ID: 22945271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iron Use in Critically Ill Patients: No More Stress?
    Rakonczay Z
    Crit Care Med; 2016 Mar; 44(3):638-9. PubMed ID: 26901550
    [No Abstract]   [Full Text] [Related]  

  • 33. Sequential treatment of anemia in ulcerative colitis with intravenous iron and erythropoietin.
    Gasche C; Dejaco C; Reinisch W; Tillinger W; Waldhoer T; Fueger GF; Lochs H; Gangl A
    Digestion; 1999; 60(3):262-7. PubMed ID: 10343140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parenteral iron therapy options.
    Silverstein SB; Rodgers GM
    Am J Hematol; 2004 May; 76(1):74-8. PubMed ID: 15114602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous iron.
    Auerbach M; Rodgers GM
    N Engl J Med; 2007 Jul; 357(1):93-4. PubMed ID: 17611217
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical characteristic of parenteral iron supplementation in hemodialysis patients receiving erythropoietin therapy.
    Kao HH; Chen KS; Tsai CJ; Lee CC; Chang HY
    Chang Gung Med J; 2000 Oct; 23(10):608-13. PubMed ID: 11126152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved response to erythropoietin therapy with long-term continuous iron supplementation.
    Descombes E; Fellay G
    Nephron; 2000 Feb; 84(2):196-7. PubMed ID: 10657727
    [No Abstract]   [Full Text] [Related]  

  • 38. A permanent tan from iron.
    Lim R; Irvine T; Ahmed MS; Abraham K; Wong CF
    Kidney Int; 2008 Apr; 73(7):898. PubMed ID: 18340355
    [No Abstract]   [Full Text] [Related]  

  • 39. Risk of iron overload and 'hemochromatosis allele(s)' in patients on maintenance hemodialysis.
    Taccone-Gallucci M; Di Nucci G; Meloni C; Mariani G; Valeri M; Piazza A; Elia L; Torromeo C; Mandelli F; Casciani CU
    Am J Nephrol; 1987; 7(1):28-32. PubMed ID: 3578371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of intravenous iron in anemia management and transfusion avoidance.
    Auerbach M; Goodnough LT; Picard D; Maniatis A
    Transfusion; 2008 May; 48(5):988-1000. PubMed ID: 18346021
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.